ArticleTranslational vision science & technology2026
Reduced Retinal Perfusion With Preserved Microvascular Network Density in Early Alzheimer's Disease: A Multimodal Imaging Study.
Article in Translational vision science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Purpose: To characterize retinal neurovascular alterations in Alzheimer's disease (AD) and mild cognitive impairment (MCI) and examine structure-function relationships. Methods: Eighty-two participants (28 with AD, 21 with MCI, and 33 cognitively normal controls) underwent retinal imaging. Retinal blood flow (RBF) was measured using a function imager. Retinal vessel density (RVD), retinal vessel length density (RVLD), vessel width, and capillary perfusion density (CPD) were quantified with optical coherence tomography (OCT) angiography and retinal tissue volume (RTV) with ultra-high-resolution OCT. Derived metrics included retinal tissue perfusion (RTP), retinal capillary flow index (RCF), and volumetric vessel density. Group comparisons and age-adjusted correlations were performed. Results: Compared with controls, the combined AD + MCI group had significantly lower RBF (3.18 ± 1.02 vs. 4.22 ± 0.79 nL/s; P < 0.001), RCF (0.21 ± 0.07 vs. 0.26 ± 0.04 nL/s/mm; P < 0.001), and RTP (2.89 ± 0.94 vs. 3.86 ± 0.77 nL/s/mm3; P < 0.001). Morphometric indices of the perfused capillary network and retinal tissue volume (RVD, RVLD, CPD, vessel width, RTV) did not differ (all P > 0.05). In AD + MCI, RBF was not associated with structural or morphometric microvascular metrics, whereas controls exhibited age-adjusted correlations between RBF and vessel density and length density. Conclusions: AD and MCI are characterized by reduced retinal perfusion and capillary flow index despite preserved network density and retinal tissue volume, suggesting altered retinal hemodynamic-morphometric relationships. Translational Relevance: Hemodynamic retinal imaging detects early perfusion impairment in AD and MCI before changes in microvascular network density or retinal tissue volume, offering a noninvasive biomarker for detection and therapeutic monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.